Publications

Abonour, R, Wagner, L, Durie, BGM, Jagannath, S, Narang, M, Terebelo, HR, Gasparetto, CJ, Toomey, K, Hardin, JW, Kitali, A, Gibson, CJ, Srinivasan, S, Swern, AS, and Rifkin, RM. "Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.(Accepted)" Annals of Hematology 97, no. 12 (December 2018): 2425-2436.

PMID
30056582
Full Text

LeBlanc, TW, and El-Jawahri, A. "Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care?(Accepted)." Current Opinion in Supportive and Palliative Care 12, no. 4 (December 2018): 530-537.

PMID
30379755
Full Text

Elnair, R, and Galal, A. "Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib." Bmc Cancer 18, no. 1 (November 12, 2018): 1097-null.

PMID
30419862
Full Text

Jamy, O, Bae, S, Costa, LJ, Erba, HP, and Papadantonakis, N. "Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow." Leukemia Research 74 (November 2018): 64-67.

PMID
30300822
Full Text

Stanland, LJ, and Luftig, MA. "Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancer." Future Virology 13, no. 11 (November 1, 2018): 803-818. (Review)

Full Text

Carpenter, PA, Logan, BR, Lee, SJ, Weisdorf, DJ, Johnston, L, Costa, LJ, Kitko, CL, Bolaños-Meade, J, Sarantopoulos, S, Alousi, AM, Abhyankar, S, Waller, EK, Mendizabal, A, Zhu, J, O'Brien, KA, Lazaryan, A, Wu, J, Nemecek, ER, Pavletic, SZ, Cutler, CS, Horowitz, MM, Arora, M, and BMT CTN., . "A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801." Haematologica 103, no. 11 (November 2018): 1915-1924.

PMID
29954931
Full Text

Mato, AR, Roeker, LE, Allan, JN, Pagel, JM, Brander, DM, Hill, BT, Cheson, BD, Furman, RR, Lamanna, N, Tam, CS, Handunnetti, S, Jacobs, R, Lansigan, F, Bhavsar, E, Barr, PM, Shadman, M, Skarbnik, AP, Goy, A, Beach, DF, Svoboda, J, Pu, JJ, Sehgal, AR, Zent, CS, Tuncer, HH, Schuster, SJ, Pickens, PV, Shah, NN, Rhodes, J, Ujjani, CS, and Nabhan, C. "Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial." American Journal of Hematology 93, no. 11 (November 2018): 1394-1401.

PMID
30132965
Full Text

Othus, M, Estey, EH, Garcia-Manero, G, Wood, BL, Stirewalt, DL, Godwin, JE, Weick, JK, Anderson, JE, Appelbaum, FR, Erba, HP, and Walter, RB. "Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials." Leukemia (October 12, 2018).

PMID
30315233
Full Text

Othus, M, Sekeres, MA, Nand, S, Garcia-Manero, G, Appelbaum, FR, Erba, HP, and Estey, E. "Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studies." Leukemia (October 12, 2018).

PMID
30315234
Full Text

Zheng, J, Sha, Y, Roof, L, Foreman, O, Lazarchick, J, Venkta, JK, Kozlowski, C, Gasparetto, C, Chao, N, Ebens, A, Hu, J, and Kang, Y. "Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade." Cancer Letters 440-441 (October 9, 2018): 1-10.

PMID
30312729
Full Text

Pages